BioPharmSignal logoBioPharmSignal

Biotech News

Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 10, 2026

Aethlon Medical (AEMD)Aethlon MedicalEarnings

AEMD (AEMD) appears in the live feed after a catalyst-style update. The headline is surfaced in real time so readers can move from signal to source without leaving the product flow.

The source domain is aemd.com. BioPharmSignal keeps the ticker, timestamp, and source together for faster review before the wider market catches up.

The original release is available below in a new tab so readers can continue into the full source when needed.

Related news

AEMDAethlon Medical2026-08-05 12:01 EST

Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 13, 2026

AEMDAethlon Medical2026-06-10 20:15 EST

Aethlon Medical Announces Fiscal Year End March 31, 2026 Financial Results and Corporate Update

REPLReplimune Group2026-06-29 12:00 EST

Replimune Reports Fiscal Fourth Quarter and Year End 2026 Financial Results and Provides Corporate Update

REGNRegeneron Pharmaceuticals2026-06-25 20:05 EST

Regeneron to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast

IMCRImmunocore Holdings plc2026-07-30 11:00 EST

Immunocore to report second quarter 2026 financial results and host call on August 6, 2026

SNDXSyndax Pharmaceuticals2026-07-28 11:00 EST

Syndax to Announce Second Quarter 2026 Financial Results and Host Conference Call and Webcast on August 4, 2026

TEVATeva Pharmaceutical Industries2026-06-18 20:30 EST

Teva to Host Conference Call to Discuss Second Quarter 2026 Financial Results on July 29, 2026 at 8 a.m. ET

IARTIntegra LifeSciences2026-07-16 12:00 EST

Integra LifeSciences to Host Second Quarter 2026 Financial Results Conference Call on July 29, 2026

EXELExelixis2026-08-05 20:05 EST

Exelixis Announces Second Quarter 2026 Financial Results and Provides Corporate Update

KYMRKymera2026-08-05 11:00 EST

Kymera Therapeutics Announces Second Quarter 2026 Financial Results and Provides a Business Update

View all latest news

Aethlon Medical

Clinical-Stage Medical Device Company Aethlon Medical is developing the Hemopurifier, an extracorporeal device designed to remove enveloped viruses and tumor-derived extracellular vesicles from blood. The company is pursuing applications in oncology, life-threatening viral infections, and other inflammation-associated...

Recent company news

AEMDAethlon Medical2026-08-05 12:01 EST

Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 13, 2026

AEMDAethlon Medical2026-07-13 12:01 EST

Aethlon Medical Continues to Observe Directional Changes in Second Cohort of Australian Oncology Clinical Trial Evaluating Hemopurifier®

AEMDAethlon Medical2026-07-06 13:25 EST

Aethlon Medical Announces Pricing of $4.0 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules

AEMDAethlon Medical2026-06-26 12:01 EST

Aethlon Medical Announces Publication Demonstrating Novel Long COVID Biomarker and Potential Therapeutic Target for the Hemopurifier®

AEMDAethlon Medical2026-06-10 20:15 EST

Aethlon Medical Announces Fiscal Year End March 31, 2026 Financial Results and Corporate Update

Stock data

Close
3.02 USD
Market cap
3.47M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States